E Fund Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 12,791 shares of RNA stock, worth $539,524. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,791
Previous 6,640
92.64%
Holding current value
$539,524
Previous $271,000
116.61%
% of portfolio
0.03%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$449 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$364 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$343 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$297 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.2B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...